Table 3.
Patients | Age (yr) | Sex | Ethnicity | IBD | Immunosupression | Serology | Viral Load (copies/mL) | HBV states |
1 | 54 | Male | White | CD | Adalimumab | HBsAg+ | 135039 | Chronic infection |
Azathioprine | Anti-HBs Ab- | |||||||
HBeAg+ | ||||||||
Anti-HBe Ab- | ||||||||
Anti-HBc Ab+ | ||||||||
2 | 56 | Female | African american | CD | - | HBsAg+ | 244 | Chronic infection |
Anti-HBs Ab- | ||||||||
Anti-HBc Ab+ | ||||||||
HBeAg- | ||||||||
3 | 56 | Female | White | CD | - | HBsAg+ | 121 | Chronic infection |
Anti-HBs Ab- | ||||||||
Anti-HBc Ab+ | ||||||||
HBeAg- | ||||||||
4 | 61 | Male | African american | CD | - | HBsAg+ | 1000000 | Chronic infection |
Anti-HBs Ab- | ||||||||
HBeAg+ | ||||||||
Anti-HBe Ab- | ||||||||
Anti-HBc Ab+ | ||||||||
5 | 54 | Female | African american | CD | Adalimumab | HBsAg- | < 10 | Past infection, |
Anti-HBs Ab+ | Naturally immune | |||||||
Anti-HBc Ab+ | ||||||||
6 | 62 | Female | African american | UC | - | HBsAg- | - | Past infection, |
Anti-HBs Ab+ | Naturally immune | |||||||
Anti-HBc Ab+ | ||||||||
7 | 64 | Female | African american | CD | Prednisolone | HBsAg- | - | Past infection, |
Anti-HBs Ab+ | Naturally immune | |||||||
Anti-HBc Ab+ |
UC: Ulcerative colitis; CD: Crohn’s disease; IBD: Inflammatory bowel disease; HBsAg: Hepatitis B surface antigen; anti-HBc Ab: Hepatitis B core antibodies.